Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Ivermectin
Chanelle Animal Health Ltd.
QP54AA01
Ivermectin
10 milligram(s)/millilitre
Solution for injection
LM: Licensed Merchant as defined in relevant national legislation
Cattle, Pigs
ivermectin
Endectoparasiticides
Authorised
2000-04-14
Health Products Regulatory Authority 27 April 2018 CRN000VZ7 Page 1 of 8 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Chanimec 10 mg/ml solution for injection for Cattle and Pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Ivermectin 10 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear colourless to slight yellow-coloured solution with no visible particulates. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (beef and non-lactating dairy cattle) and Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections with the following parasites in beef and non-lactating dairy cattle or pigs: CATTLE: GASTRO-INTESTINAL ROUNDWORMS (adult and fourth stage larvae): _Ostertagia spp. _(including inhibited _O. ostertagi)_ _Haemonchus placei_ _Trichostrongylus axei_ _Trichostrongylus colubriformis_ _Cooperia spp._ _Oesophagostomum radiatum_ _Nematodirus helvetianus (_adult_)_ _N. spathiger _(adult) LUNGWORMS (adult and fourth stage larvae): _Dictyocaulus viviparus._ WARBLES: _Hypoderma bovis_ Health Products Regulatory Authority 27 April 2018 CRN000VZ7 Page 2 of 8 _H. lineatum._ MANGE MITES: _Psoroptes bovis_ _Sarcoptes scabiei _var_. bovis._ SUCKING LICE: _Linognathus vituli_ _Haematopinus eurysternus_ PIGS: GASTROINTESTINAL ROUNDWORMS: (adult and fourth stage larvae): _Ascaris suum_ _Hyostrongylus rubidus_ _Oesophagostomum _spp. _Strongylides ransomi _(adult only and somatic larval stage) LUNGWORMS: _Metastrongylus _spp_. _(adult) LICE: _Haematopinus suis_ MANGE MITES: _Sarcoptes scabiei _var_. suis_ The use of the product in cattle should take into account geographical differences in the occurrence patterns of parasites. 4.3 CONTRAINDICATIONS Do not administer by the intravenous or intramuscular route. Do not use in animals with known hypersensitivity to the active ingredient. Do not use in dogs or cats as severe adverse reactions may occur (see also section 4.5). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPE Lees het volledige document